LPTX News and Press, Leap Therapeutics Inc. From 03/11/22

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire CAMBRIDGE, Mass. , March 11, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference PR Newswire CAMBRIDGE, Mass. , March 2, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-onc...

I bought LPTX stock expecting a quick profit after a spike following data. The spike did happen, but I bought a little too high. I am expecting part B data to be strong enough for me to make a profit and exit. For further details see: Leap Therapeutics: Waiting For One M...

Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics' DKK1 inhibitor, DKN-01 PR Newswire CAMBRIDGE, M...

Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference PR Newswire CAMBRIDGE, Mass. , Jan. 24, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology th...

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer, across the world. The high mortality rates are pr...

Shares of Leap Therapeutics (NASDAQ: LPTX) , a clinical-stage biopharmaceutical company , are surging in response to positive clinical results from a stomach cancer study. Investors excited about the company's lead candidate, DKN-1, drove the stock 10.3% higher as of 12:55 p.m. ...

Tech and biotech stocks on the Nasdaq Stock Market have been taking a beating lately. Narrative-driven growth stocks have fallen out of favor since the start of last December due to the uncertainty created by sky-high inflation rates, the omicron variant, and the Federal Reserve's possi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re diving right into trading today with the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning are clinical trials, ear...

Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium - DKN-01 plus tislelizumab demonstrated encouraging clinical activity in both first- and second-line advanced gastric or gastroesophageal juncti...